Geoffrey Varty

About

Geoffrey Varty is the Head of R&D at Cybin in the United States. His research focuses on the synthesis and structure-activity relationships of novel compounds, particularly in the context of serotonin 5-HT2 receptor agonists and muscarinic M-4 positive allosteric modulators. Recent articles authored by Varty highlight advancements in the development of orally bioavailable compounds and their effects in rodent pain models.